Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000623825 | SCV000740686 | pathogenic | Inborn genetic diseases | 2017-09-13 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV002248819 | SCV002517944 | uncertain significance | not specified | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV002254937 | SCV002526198 | pathogenic | not provided | 2022-06-10 | criteria provided, single submitter | clinical testing | Reported as de novo in an individual with multiple congenital anomalies in a study on candidate genes, however, specific clinical information was not provided (Farwell Hagman et al., 2017); please note this variant is referred to as E867Rfs*23 using alternate nomenclature; Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 27513193, 26899553) |